Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants

Kalyan DAS; Arthur D CLARK; Bart DE CORTE; Robert W KAVASH; Chih Y HO; HONG YE; Mark A LICHTENSTEIN; Koen ANDRIES; Rudi PAUWELS; Marie-Pierre DE BETHUNE; Paul L BOYER; Patrick CLARK; Paul J LEWI; Stephen H HUGHES; Paul A. J JANSSEN; Eddy ARNOLD; Jan HEERES; Marc R DE JONGE; Lucien M. H KOYMANS; H. Maarten VINKERS; Frederik DAEYAERT; Donald W LUDOVICI; Michael J KUKLA

doi:10.1021/jm030558s

Back

Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants

Journal article

Peer reviewed

Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants

Kalyan DAS, Arthur D CLARK, Bart DE CORTE, Robert W KAVASH, Chih Y HO, HONG YE, Mark A LICHTENSTEIN, Koen ANDRIES, Rudi PAUWELS, Marie-Pierre DE BETHUNE, …

Journal of medicinal chemistry, Vol.47(10), pp.2550-2560

2004

DOI: https://doi.org/10.1021/jm030558s

PMID: 15115397

Abstract

Antiviral agents

Biological and medical sciences

Medical sciences

Pharmacology. Drug treatments

Antibiotics. Antiinfectious agents. Antiparasitic agents

Metrics

12 Record Views

466 Times Cited - Web of Science

See more details

Details

Title: Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants
Creators: Kalyan DAS - Center for Advanced Biotechnology and Medicine and Department of Chemistry and Chemical Biology, Rutgers University, Piscataway, New Jersey 08854, United States
Arthur D CLARK - Center for Advanced Biotechnology and Medicine and Department of Chemistry and Chemical Biology, Rutgers University, Piscataway, New Jersey 08854, United States
Bart DE CORTE - Janssen Research Foundation, Spring House, Pennsylvania, United States
Robert W KAVASH - Janssen Research Foundation, Spring House, Pennsylvania, United States
Chih Y HO - Janssen Research Foundation, Spring House, Pennsylvania, United States
HONG YE - Janssen Research Foundation, Spring House, Pennsylvania, United States
Mark A LICHTENSTEIN - Janssen Research Foundation, Spring House, Pennsylvania, United States
Koen ANDRIES - Tibotec, 2800 Mechelen, Belgium
Rudi PAUWELS - Tibotec, 2800 Mechelen, Belgium
Marie-Pierre DE BETHUNE - Tibotec, 2800 Mechelen, Belgium
Paul L BOYER - HIV Drug Resistance Program, NIH National Cancer Institute-Frederick, Frederick, Maryland 21702, United States
Patrick CLARK - HIV Drug Resistance Program, NIH National Cancer Institute-Frederick, Frederick, Maryland 21702, United States
Paul J LEWI - Center for Molecular Design, Janssen Pharmaceutica NV, Vosselaar, Belgium
Stephen H HUGHES - HIV Drug Resistance Program, NIH National Cancer Institute-Frederick, Frederick, Maryland 21702, United States
Paul A. J JANSSEN - Center for Molecular Design, Janssen Pharmaceutica NV, Vosselaar, Belgium
Eddy ARNOLD - Center for Advanced Biotechnology and Medicine and Department of Chemistry and Chemical Biology, Rutgers University, Piscataway, New Jersey 08854, United States
Jan HEERES - Center for Molecular Design, Janssen Pharmaceutica NV, Vosselaar, Belgium
Marc R DE JONGE - Center for Molecular Design, Janssen Pharmaceutica NV, Vosselaar, Belgium
Lucien M. H KOYMANS - Center for Molecular Design, Janssen Pharmaceutica NV, Vosselaar, Belgium
H. Maarten VINKERS - Center for Molecular Design, Janssen Pharmaceutica NV, Vosselaar, Belgium
Frederik DAEYAERT - Center for Molecular Design, Janssen Pharmaceutica NV, Vosselaar, Belgium
Donald W LUDOVICI - Janssen Research Foundation, Spring House, Pennsylvania, United States
Michael J KUKLA - Janssen Research Foundation, Spring House, Pennsylvania, United States
Publication Details: Journal of medicinal chemistry, Vol.47(10), pp.2550-2560
Date published: 2004
Publisher: American Chemical Society
Academic Unit: Center for Advanced Biotechnology and Medicine
Language: English
Resource Type: Journal article
Identifiers: 991031654834204646